Home
Welcome
Our research objective is to discover the fundamental mechanisms that underlie human disease.
News
ARC Hub for Therapeutics - Accelerating Research to Commercialisation
The ARC Hub for Therapeutics is a national initiative that accelerates cutting-edge biomedical research into real-world therapies launched in 2025.
Young Academy Ireland welcomes new members
Congratulations to Dr Mary Canavan on being included among the 21 new members of the Young Academy Ireland (YAI) at the Royal Irish Academy last week. Dr Canavan will begin a four-year term, working on initiatives that strengthen research and enrich cultural life across the island of Ireland. We wish Mary well with her future endeavours!
Aurora Women in Leadership Programme
Congratulations to Sinead O’Rourke (of Aisling Dunne’s group) and Fay Ma (of Ed Lavelle’s group) from the School of Biochemistry and Immunology who graduated on 18 March from the Aurora Women in Leadership Programme.
Sustainability leadership awards
Dr Anne McGettrick Dillon who won a Sustainability Leadership Award, on behalf of the O’Neill lab.
Higher Options 2025
Thanks to Prof Cliona O’Farrelly and postgraduate students Jessica Davis and Anna Bessenyei who flew the flag for our school at Higher Options recently.
ARC Hub for Therapeutics led by Prof Vincent Kelly
Trinity to headquarter new €31.6 million Research Ireland ARC Hub for Therapeutics. Vincent Kelly, Professor in Trinity’s School of Biochemistry and Immunology, will direct the ARC Hub for Therapeutics, which will be headquartered in the Trinity Biomedical Sciences Institute.
